1
TÍTULO: Injection site reactions from an integrated analysis of phase 2 and phase 3 clinical trials of lebrikizumab treatment in moderate-to-severe atopic dermatitis  Full Text
AUTORES: Gooderham, Melinda; Shi, Vivian Y.; Wollenberg, Andreas; Thyssen, Jacob P.; Torres, Tiago; Gil, Esther Garcia; Bardolet, Laia; Natalie, Chitra R.; Atwater, Amber R.; Zhao, Fangyi; Blauvelt, Andrew;
PUBLICAÇÃO: 2023, FONTE: BRITISH JOURNAL OF DERMATOLOGY, VOLUME: 188
INDEXADO EM: WOS